BREAKING
Operational Efficiency Powers MGY to Historic Production and Dividend Lift 42 minutes ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 46 minutes ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 50 minutes ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 3 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 3 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 3 days ago Abbott reports positive results from study on its atrial fibrillation therapies 3 days ago Atmus Welcomes Heath Sharp to Board of Directors 3 days ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 42 minutes ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 46 minutes ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 50 minutes ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 3 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 3 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 3 days ago Abbott reports positive results from study on its atrial fibrillation therapies 3 days ago Atmus Welcomes Heath Sharp to Board of Directors 3 days ago
ADVERTISEMENT
AlphaGraphs

Pfizer (PFE) Q2 2024 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported its second quarter 2024 earnings results today. Revenues increased 2% year-over-year to $13.3 billion. Revenues grew 3% operationally. Reported net income fell 98% to $41 million, or $0.01 per share, compared to last year. Adjusted EPS dropped 11% to $0.60. For the full year of 2024, Pfizer expects revenues of […]

$PFE July 30, 2024 1 min read

Pfizer Inc. (NYSE: PFE) reported its second quarter 2024 earnings results today.

Revenues increased 2% year-over-year to $13.3 billion. Revenues grew 3% operationally.

Reported net income fell 98% to $41 million, or $0.01 per share, compared to last year. Adjusted EPS dropped 11% to $0.60.

For the full year of 2024, Pfizer expects revenues of $59.5-62.5 billion. Adjusted EPS is expected to be $2.45-2.65.

Prior performance

ADVERTISEMENT